Xigris Growth Tied To Patient Selection As Hospitals Wrestle With Protocols

The growth of Xigris will be tied to helping hospitals identify appropriate patients for the sepsis agent, Lilly suggested during a Jan. 24 earnings conference call

More from Archive

More from Pink Sheet